Will Aphria stock rise or fall in 2021?
Wall Street analysts are bearish on Aphria stock in 2021. According to data compiled by TipRanks, their average one-year price target for Aphria is $12.46, which is almost 48 percent below its current price. The stock is also trading 16 percent above analysts' highest price target of $20.42.
What is the price target for Aphria?
The average twelve-month price target for Aphria is $22.75 with a high price target of $32.50 and a low price target of $15.00. Learn more Do Wall Street analysts like Aphria more than its competitors? Analysts like Aphria stock less than the stock of other Medical companies.
Does Aphria's (APH) stock have much upside?
Does Aphria's stock price have much upside? According to analysts, Aphria's stock has a predicted upside of 44.44% based on their 12-month price targets. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
What is the return on equity of Aphria?
Aphria had a negative trailing twelve-month return on equity of 2.30% and a negative net margin of 36.10%. Aphria's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.02 EPS. View Aphria's earnings history. What price target have analysts set for APHA?
See more
What is the Forecast for APHA stock?
Aphria Inc quote is equal to 17.230 USD at 2022-07-23. Based on our forecasts, a long-term increase is expected, the "APHA" stock price prognosis for 2026-07-01 is 58.128 USD.
Should I sell my Aphria stocks?
Aphria Inc(APHA-T) Rating Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
What happens to my Canadian Aphria stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Why is Aphria stock dropping?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.
Will Aphria stock become Tilray?
Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned.
What is Aphria called now?
Last week, Tilray (TLRY) and Aphria formally merged to form a new company. It instantly became the industry leader in the Canadian pot market.
What is the new stock symbol for Aphria?
What is Aphria's stock symbol? Aphria trades on the NASDAQ under the ticker symbol "APHA."
Who purchased Aphria?
TilrayIrwin D Simon, formerly Aphria's CEO and chairman, will lead the new Tilray, with Tilray's current CEO Brendan Kennedy joining the board. Tilray shareholders voted in favor of the deal on Friday. Aphria shareholders received 0.8381 of a Tilray share for each Aphria common share owned.
What brands does Aphria own?
Aphria offers multiple products under a portfolio of recreational cannabis brands, including Good Supply, B! NGO, Solei, RIFF, and Broken Coast. In November 2020, Aphria acquired SweetWater Brewing Company, one of the largest craft breweries in the USA.
Is Aphria a good buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.
Is Aphria stock a good investment?
Because Aphria is relatively undervalued, the long-term return of its stock is likely to be higher than its business growth, which averaged 125.7% over the past three years and is estimated to grow 26.56% annually over the next three to five years.
Who did Aphria merge with?
TilrayThe two cannabis companies announced in December that they will merge under the Tilray name with Aphria CEO Irwin Simon at the helm and Tilray CEO Brendan Kennedy joining the board. Aphria will lose its name and independent stock symbol on Wednesday.
Is Aphria a good buy right now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.
Will Tilray come back up?
The average one-year Tilray share price forecast is $10.31 a potential upside of 28%.
Should I sell my Tilray stock?
(TLRY-Q) Rating. Stockchase rating for Tilray Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Should I sell Neptune wellness?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Neptune Wellness Solutions stock.
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quart...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Tilray (TLRY) , Canopy Growth (CGC) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria (NASDAQ:APHA) has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 mil...
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
What is Aphria's official website?
The official website for Aphria is aphriainc.com .
Aphria (NASDAQ:APHA) Price Target and Consensus Rating
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Price Target Consensus
Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.
Analyst Ratings By Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Average Share Price and Price Target by Month
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
Aphria (NASDAQ:APHA) Analyst Ratings Frequently Asked Questions
According to the issued ratings of 5 analysts in the last year, the consensus rating for Aphria stock is Hold based on the current 3 hold ratings and 2 buy ratings for APHA. The average twelve-month price target for Aphria is $22.25 with a high price target of $26.00 and a low price target of $18.00. Learn more on APHA's analyst rating history
What is the rating of Aphria?
Aphria has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 3 buy ratings, 5 hold ratings, and no sell ratings.
What is the official website for Aphria?
The official website for Aphria is aphriainc.com.
What is the APHA symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
How many hold ratings are there for Aphria?
There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
Where is Aphria located?
The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Is Aphria a hold stock?
Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them.
Does Aphria pay dividends?
Aphria does not currently pay a dividend.
APHA Consensus Estimates
Our Aphria Inc stock price forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Aphria stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month APHA price targets.
Recent Sentiments
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
